Publications by authors named "Joanna Assadourian"
Background: Dietary supplement use is prevalent in the general US population, but little is known regarding the driving reasons for their use among those with atherosclerotic cardiovascular disease (ASCVD).
Methods And Results: Data from the National Health and Nutrition Examination Survey (NHANES) from 2017 to March 2020 were used to identify adults with ASCVD. Supplement use was assessed by interviewers using label review, and surveys captured self-reported reasons for use.
Article Synopsis
- Visual coronary artery calcium (CAC) can be detected through routine chest CT scans, but accuracy in scoring may vary depending on the radiologist’s specialty and the use of contrast.
- A study involving 934 patients assessed the correlation between visual CAC estimation on non-gated CT scans and actual CAC scores, finding a strong correlation overall, especially among those with moderate-to-large CAC.
- The absence of visible CAC on non-gated scans does not necessarily indicate low cardiovascular risk, particularly in patients whose scans were enhanced with contrast or interpreted by non-specialist radiologists.
Importance: One in 5 US adults older than 60 years takes fish oil supplements often for heart health despite multiple randomized clinical trials showing no data for cardiovascular benefit for supplement-range doses. Statements on the supplement labels may influence consumer beliefs about health benefits.
Objectives: To evaluate health claims made on the labels of fish oil supplements in the US, and to examine doses of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in commonly available formulations.
Background We compared the cognitive status and quality of life in patients with atrial fibrillation undergoing left atrial appendage occlusion (LAAO) or remaining on oral anticoagulation (OAC) after atrial fibrillation ablation. Methods and Results Cognition was assessed by the Montreal Cognitive Assessment (MoCA) survey at baseline and follow-up. Consecutive patients receiving LAAO or OAC after atrial fibrillation ablation were screened, and patients with a score of ≤17 were excluded from the study.
View Article and Find Full Text PDF